Controlling Cancer Pain Requires Detailed Planning and Persistent Effort by Committed Interdisciplinary Team

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 6
Volume 11
Issue 6

BALTIMORE-Between 65% and 85% of advanced cancer patients suffer pain, but between 85% and 95% of those patients, if properly treated, can experience relief. Providing effective pain management is a multidisciplinary effort requiring detailed planning and persistent implementation by a team committed to using a variety of resources and techniques. These concepts and how they are integrated into the Johns Hopkins approach to pain management were described by Suzanne A. Nesbit, PharmD, BCPS, clinical specialist in pain management in the Department of Pharmacy at Johns Hopkins Hospital in Baltimore and Kathy Smolinski, LCSW-C, senior clinical social worker in the Cancer Pain Service of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

BALTIMORE—Between 65% and 85% of advanced cancer patients suffer pain, but between 85% and 95% of those patients, if properly treated, can experience relief. Providing effective pain management is a multidisciplinary effort requiring detailed planning and persistent implementation by a team committed to using a variety of resources and techniques. These concepts and how they are integrated into the Johns Hopkins approach to pain management were described by Suzanne A. Nesbit, PharmD, BCPS, clinical specialist in pain management in the Department of Pharmacy at Johns Hopkins Hospital in Baltimore and Kathy Smolinski, LCSW-C, senior clinical social worker in the Cancer Pain Service of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Controlling Pain

Central to the Hopkins approach is the belief that "communication is the key" to properly assessing and controlling pain, Ms. Smolinski said at an industry-sponsored symposium held in conjunction with the Oncology Nursing Society annual meeting. As a first step toward pain control, each cancer patient seen at Hopkins completes a common problem checklist. The answers help members of the Cancer Pain Service combine assessing a patient’s level of pain with educating him or her about pain control, Dr. Nesbit said.

Pain Rated Daily

The program includes a pain rating done for each patient daily, she continued. Anyone reporting a pain level of four or higher is evaluated by the pain service, which is committed to "return [to the patient’s case] relentlessly until the pain is managed," Dr. Nesbit said. Special rounds and weekly case conferences also concentrate on controlling each patient’s pain. To help streamline the pain control team’s work, the special data base being developed can be accessed by a palm-held computer.

Patients overwhelmingly report that their nurses are the best source for education about pain management, Ms. Smolinski added. Because patients often feel unsure what or how to ask, nurses at Hopkins use handouts, including a question and answer sheet intended both to answer patients’ unspoken questions and to encourage discussion. At discharge, each patient also receives specific pain management instructions, she noted.

Recent Videos
A new partnership agreement involving AI use may help spread radiotherapeutic standards from academic centers to more patients in community-based practices.
For example, you have a belt of certain diseases or genetic disorders that you come across, such as sickle cell disease or thalassemia, that are more prevalent in these areas.
Recent findings presented at ASTRO 2025 suggest an “exciting opportunity” to expand the role of radiation oncology in different non-malignant indications.
The 3 most likely directions of radiotherapy advancements come from new technology, combinations with immunotherapy, and the incorporation of particle therapy.
Talent shortages in the manufacturing and administration of cellular therapies are problems that must be addressed at the level of each country.
Administering oral SERD-based regimens may enhance patients’ quality of life when undergoing treatment for ER-positive, HER2-negative breast cancer.
4 experts in this video
4 experts in this video